Utah Medical Products Inc
UTMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000706698
No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Utah Medical Products Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +11 vs. Q4 2023
- Shares held
- 2.49M
- −25.2K (−1.0%) vs. Q4 2023
- Total value
- $177.1M
- −$34.8M (−16.4%) vs. Q4 2023
- New holders
- 21
- 36 more added
- Sold out
- 10
- 31 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UTMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $159.9M |
| Q1 2026 | 120 | $140.5M |
| Q4 2025 | 117 | $117.5M |
| Q3 2025 | 117 | $136.5M |
| Q2 2025 | 112 | $122.9M |
| Q1 2025 | 110 | $125.6M |
| Q4 2024 | 112 | $141.7M |
| Q3 2024 | 110 | $161.2M |
| Q2 2024 | 101 | $162.1M |
| Q1 2024 | 100 | $177.1M |
| Q4 2023 | 89 | $211.9M |
| Q3 2023 | 92 | $221.3M |
| Q2 2023 | 90 | $237.5M |
| Q1 2023 | 87 | $241.0M |
| Q4 2022 | 82 | $256.0M |
| Q3 2022 | 78 | $216.3M |
| Q2 2022 | 75 | $219.9M |
| Q1 2022 | 85 | $231.2M |
| Q4 2021 | 79 | $260.4M |
| Q3 2021 | 72 | $241.5M |
| Q2 2021 | 68 | $221.1M |
| Q1 2021 | 79 | $228.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Utah Medical Products Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −269,166−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −16,657−100.0% | Sold out |
| James Investment Research Inc | 0 | $0 | 0.00% | −4,292−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −3,718−100.0% | Sold out |
| Morgan Dempsey Capital Management LLC | 0 | $0 | 0.00% | −896−100.0% | Sold out |
| Northwest Financial Advisors | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −233−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |